NJ State Employees Deferred Compensation Plan’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Hold |
|
|||||
|
2025
Q1 | $360K | Hold |
|
|||||
|
2024
Q4 | $336K | Hold |
|
|||||
|
2024
Q3 | $324K | Hold |
|
|||||
|
2024
Q2 | $164K | Hold |
|
|||||
|
2024
Q1 | $296K | Hold |
|
|||||
|
2023
Q4 | $290K | Hold |
|
|||||
|
2023
Q3 | $216K | Hold |
|
|||||
|
2023
Q2 | $258K | Hold |
|
|||||
|
2023
Q1 | $264K | Hold |
|
|||||
|
2022
Q4 | $300K | Hold |
|
|||||
|
2022
Q3 | $236K | Hold |
|
|||||
|
2022
Q2 | $226K | Hold |
|
|||||
|
2022
Q1 | $598K | Hold |
|
|||||
|
2021
Q4 | $530K | Hold |
|
|||||
|
2021
Q3 | $726K | Hold |
|
|||||
|
2021
Q2 | $868K | Hold |
|
|||||
|
2021
Q1 | $684K | Hold |
|
|||||
|
2020
Q4 | $700K | Hold |
|
|||||
|
2020
Q3 | $480K | Hold |
|
|||||
|
2020
Q2 | $366K | Hold |
|
|||||
|
2020
Q1 | $312K | Hold |
|
|||||
|
2019
Q4 | $428K | Hold |
|
|||||
|
2019
Q3 | $374K | Hold |
|
|||||
|
2019
Q2 | $522K | Hold |
|
|||||
|
2019
Q1 | $514K | Hold |
|
|||||
|
2018
Q4 | $460K | Buy |
|
|||||
|
2018
Q3 | $578K | Buy |
|
|||||
|
2018
Q2 | $311K | Sell |
|
|||||
|
2018
Q1 | $531K | Hold |
|
|||||
|
2017
Q4 | $582K | Sell |
|
|||||
|
2017
Q3 | $737K | Sell |
|
|||||
|
2017
Q2 | $969K | Hold |
|
|||||
|
2017
Q1 | $1.18M | Hold |
|
|||||
|
2016
Q4 | $845K | Hold |
|
|||||
|
2016
Q3 | $1.3M | Buy |
|
|||||
|
2016
Q2 | $569K | Hold |
|
|||||
|
2016
Q1 | $645K | Hold |
|
|||||
|
2015
Q4 | $773K | Hold |
|
|||||
|
2015
Q3 | $630K | Buy |
|